Share Options

RNS Number : 7889M

Immupharma PLC

04 February 2009

 



For Immediate Release

4 February 2009

ImmuPharma PLC

Grant of Options

ImmuPharma PLC (LSE:IMM), ('ImmuPharma' or the 'Company'), the specialist drug discovery and development company, granted today share options to certain of its employees and Directors.  The Company has adopted a HM Revenue & Customs approved share ownership plan (CSOP) and an unapproved share option scheme.

The amount of options granted are summarised in the following table:

Director	Options Granted
Richard Warr	140,000
Robert Zimmer	150,000
Dimitri Dimitriou	140,000
Franco di Muzio	100,000
Ajay Agrawal	100,000

The share options provide the right to subscribe for ordinary shares of 10 pence each in the Company at a price of 86.5 pence each, the closing middle market price on 3 February 2009. The options are exercisable between 3 years and 10 years from the date of grant.

For further information, please contact:

ImmuPharma PLC

Dimitri Dimitriou, Chief Executive Officer                                           020 7152 4080

Richard Warr, Chairman                                                                               020 7152 4080

Dr Robert Zimmer, President & Chief Scientific Officer                [phone]

Panmure Gordon & Co (Nominated Advisor and Broker)

Andrew Burnett / Rakesh Sharma (Corporate Finance)                 020 7459 3600

Ashton Clanfield (Corporate Broking)

Buchanan Communications                                                                       020 7466 5000

Lisa Baderoon

Rebecca Skye Dietrich

 

END

 

 

RDSFGGGZZDMGLZM